Today: 7 February 2026
Subscribe
Browse Category

Earnings Reports News 3 December 2025

Pembina Pipeline (TSX:PPL, NYSE:PBA) Stock: Dividend Yield, Q3 Earnings Miss and LNG Growth – December 3, 2025 Update

Pembina Pipeline (TSX:PPL, NYSE:PBA) Stock: Dividend Yield, Q3 Earnings Miss and LNG Growth – December 3, 2025 Update

Updated: December 3, 2025 Pembina Pipeline Corporation’s stock is back on radar for dividend investors and energy‑infrastructure watchers. As of early trading on December 3, 2025, the Canadian midstream giant is trading near its 52‑week mid‑range with a chunky yield, a recent earnings miss, but increasingly clear long‑term growth from LNG and data‑center‑driven demand.StockAnalysis+1 Below is a round‑up of the most important news, forecasts and analyses on Pembina Pipeline Corporation (PPL/PBA) as of December 3, 2025, and what they mean for investors. Quick snapshot: Pembina Pipeline stock today On both exchanges, Pembina trades like a steady, low‑beta income stock (beta
3 December 2025
·
Macy’s (M) Stock Slips After Surprise Q3 Profit and Raised 2025 Outlook: What Investors Need to Know Today

Macy’s (M) Stock Slips After Surprise Q3 Profit and Raised 2025 Outlook: What Investors Need to Know Today

As of the morning of December 3, 2025, Macy’s, Inc. (NYSE: M) is back in the spotlight. The department store chain delivered a surprise third‑quarter profit, its strongest comparable sales growth in more than three years, and raised full‑year guidance — yet the stock is trading lower after management struck a cautious tone on the all‑important holiday quarter. Reuters+1 Macy’s shares were recently changing hands around $22.55, down about 0.7% on the day and slightly below Tuesday’s close of $22.71. That still leaves the stock near its 52‑week high of $23.15 and up sharply from a 52‑week low of $9.76,
3 December 2025
·
Royal Bank of Canada (RY) Stock: Record 2025 Earnings, Dividend Hike and 2026 Outlook

Royal Bank of Canada (RY) Stock: Record 2025 Earnings, Dividend Hike and 2026 Outlook

Royal Bank of Canada stock (TSX: RY, NYSE: RY) is back in the spotlight after delivering record 2025 earnings, hiking its dividend and drawing a wave of fresh analyst upgrades on December 3, 2025. New guidance, an auditor’s confirmation of financial health and ongoing integration of HSBC Canada are all reshaping the investment narrative around Canada’s largest bank. Newswire+2TipRanks+2 Below is a detailed look at today’s news, the latest forecasts, and how analysts now view Royal Bank of Canada stock. RBC stock today: price, valuation and performance On the NYSE, Royal Bank of Canada shares trade around US$154 as of
3 December 2025
National Bank of Canada (TSX: NA) Stock Soars After Q4 2025 Earnings Beat and Dividend Hike – What It Means for 2026

National Bank of Canada (TSX: NA) Stock Soars After Q4 2025 Earnings Beat and Dividend Hike – What It Means for 2026

On December 3, 2025, National Bank of Canada (TSX: NA, OTC: NTIOF) reported strong fourth‑quarter and full‑year results, raised its common share dividend, and doubled down on its expansion strategy via major acquisitions. All of this comes with the stock trading near record highs and analysts increasingly split between “Buy” and “Hold.” Below is a detailed look at today’s news, fresh forecasts and analyst views, and what they imply for National Bank of Canada stock in 2026. Key Takeaways Q4 2025 Results: A Big Beat Driven by Fee Businesses and CWB Strong top‑ and bottom‑line growth For the quarter ended
3 December 2025
·
CIBC (CM) Stock Near Year Highs Ahead of Q4 2025 Earnings – Latest News, Analyst Forecasts and Dividend Outlook

CIBC (CM) Stock Near Year Highs Ahead of Q4 2025 Earnings – Latest News, Analyst Forecasts and Dividend Outlook

Toronto – December 3, 2025.Canadian Imperial Bank of Commerce (CIBC, TSX: CM; NYSE: CM) heads into its fourth‑quarter 2025 earnings report trading just shy of its 52‑week highs, after a strong year for Canadian bank stocks and a fresh wave of research, trading plans and institutional filings hitting the tape today. On the Toronto Stock Exchange, CIBC’s shares closed on December 2 at C$119.50, after trading between C$119.67 and C$121.08, keeping them within touching distance of a recent intraday peak around C$122.56.Investing.com+1 On the NYSE, the U.S.-listed CM shares finished Tuesday at US$86.59, up about 30% over the past 12
3 December 2025
·
GitLab (GTLB) Stock Falls on Cautious FY26 Outlook Despite Strong Q3 Earnings Beat

GitLab (GTLB) Stock Falls on Cautious FY26 Outlook Despite Strong Q3 Earnings Beat

Date: December 3, 2025Ticker: GitLab Inc (NASDAQ: GTLB) GitLab Inc. (GTLB) is having a volatile session on Wednesday as Wall Street digests a classic “good quarter, cautious guide” story. After reporting better‑than‑expected third‑quarter fiscal 2026 results on December 2, GitLab shares dropped roughly 9–11% in after‑hours and pre‑market trading, touching the high‑$30s before recovering toward the low‑$40s. Chartmill+2StockAnalysis+2 Around midday on December 3, the stock was trading near $43.37, giving the DevSecOps platform a market value in the mid‑single‑digit billions of dollars. StockAnalysis Before this week’s earnings, GitLab stock was already down in the mid‑20% range year to date in
3 December 2025
··
Bank of Montreal (BMO) Stock on December 3, 2025: Walmart Deal, Q4 Earnings Preview and 2026 Outlook

Bank of Montreal (BMO) Stock on December 3, 2025: Walmart Deal, Q4 Earnings Preview and 2026 Outlook

Bank of Montreal stock is heading into a pivotal week, with a fresh Walmart Canada partnership, new payment APIs, and a closely watched Q4 2025 earnings report all hitting the tape at once. Here’s what investors need to know today. Where Bank of Montreal stock stands on December 3, 2025 On the New York Stock Exchange, Bank of Montreal (NYSE: BMO) last closed around US$126 per share, with a market capitalization close to US$90 billion. Trailing twelve‑month earnings per share (EPS) sit just above US$8, implying a price‑to‑earnings ratio around 15x and a forward P/E near 13–14x, according to StockAnalysis
3 December 2025
····
TD Bank Stock in December 2025: Outlook Ahead of Q4 Earnings, AML Fallout and the “Back to Winning” Turnaroundcc

TD Bank Stock in December 2025: Outlook Ahead of Q4 Earnings, AML Fallout and the “Back to Winning” Turnaroundcc

As of December 3, 2025, Toronto‑Dominion Bank (NYSE: TD, TSX: TD) is trading just below its all‑time highs, after a spectacular 50%+ rally this year. That surge comes even as the bank works through the fallout of a record US anti‑money‑laundering (AML) settlement, a fast‑tracked CEO transition, and an ambitious cost‑cutting and AI‑driven growth strategy. With Q4 2025 earnings due tomorrow and fresh research notes landing today, TD Bank stock is in the spotlight for global investors. Here’s a deep, news‑driven look at where things stand right now. Where TD Bank Stock Trades Today On the New York Stock Exchange,
3 December 2025
··
Royal Bank of Canada (RY, RY.TO) Stock: Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

Royal Bank of Canada (RY, RY.TO) Stock: Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

Published December 3, 2025 – Informational article, not investment advice. Royal Bank of Canada stock is back in the spotlight after the country’s largest lender delivered record fiscal 2025 results, raised its dividend and lifted its profitability target for 2026. With the share price hovering near all‑time highs and analyst targets pointing to only modest upside, investors are asking the obvious question: is RBC stock still a buy after this big run? Below is a detailed look at today’s news, the latest numbers and what analysts now expect for Royal Bank of Canada (TSX: RY, NYSE: RY). Where Royal Bank
3 December 2025
····
Dollar Tree Stock (DLTR): Q3 2025 Earnings Beat, Higher Profit Outlook and What It Means for Investors

Dollar Tree Stock (DLTR): Q3 2025 Earnings Beat, Higher Profit Outlook and What It Means for Investors

Dollar Tree, Inc. (NASDAQ: DLTR) just delivered a decisive Q3 2025 update on 3 December 2025, beating Wall Street expectations, raising its full‑year profit outlook, and underscoring how far its transformation has come since selling Family Dollar earlier this year.Dollar Tree, Inc.+1 For investors watching discount retail as consumers continue to trade down, Dollar Tree is suddenly one of the most interesting stories on the shelf. Dollar Tree stock today: a quick snapshot Despite the rally, Wall Street’s stance is cautious rather than euphoric: most analyst services classify DLTR as a “Hold”, with average 12‑month price targets sitting very close
3 December 2025
··
Bank of Nova Scotia (BNS) Stock: Q4 2025 Earnings Beat, Dividend Boost and 2026 Outlook

Bank of Nova Scotia (BNS) Stock: Q4 2025 Earnings Beat, Dividend Boost and 2026 Outlook

Published: December 3, 2025 – Informational article, not investment advice. Key takeaways for BNS stock today Share price: Bank of Nova Scotia (Scotiabank) trades around US$70.55 on the NYSE, up roughly 3% on the day. Fresh record in Toronto: The TSX listing recently hit a record high near C$99.34 after earnings.Reuters Q4 2025 beat: Adjusted EPS of C$1.93 topped consensus (~C$1.84) and revenue also came in above expectations.MarketScreener Australia+3Reuters+3Mortgage Professional Australia+3 Dividend: Scotiabank confirmed a C$1.10 quarterly dividend (Dividend No. 626), payable January 28, 2026, keeping the yield in the mid‑4% range at current prices.Newswire+1 Street view: Consensus is a
3 December 2025
·
Suncor Energy (SU) Stock: Dividend Hike, Q3 2025 Beat and Analyst Outlook as of December 3, 2025

Suncor Energy (SU) Stock: Dividend Hike, Q3 2025 Beat and Analyst Outlook as of December 3, 2025

Suncor Energy Inc. (TSX: SU, NYSE: SU) enters December 3, 2025 at the centre of investor attention: the stock is trading near its 52‑week high, it just went ex‑dividend on an increased payout, and analysts continue to ratchet price targets higher following a record third quarter. MarketBeat+2Suncor+2 Below is a deep dive into the latest news, forecasts and analysis around Suncor Energy stock as of December 3, 2025, designed for readers following the name on Google News and Discover. Key Takeaways 1. Suncor Energy Stock Snapshot on December 3, 2025 As of early trading on December 3, 2025, Suncor’s NYSE
3 December 2025
·····
POET Technologies (NASDAQ: POET) Stock on December 3, 2025: Cash-Rich AI Optics Play Faces Sharp Volatility After Q3 Earnings

POET Technologies (NASDAQ: POET) Stock on December 3, 2025: Cash-Rich AI Optics Play Faces Sharp Volatility After Q3 Earnings

POET stock price today: where things stand on 3 December 2025 As of the U.S. midday session on December 3, 2025, POET Technologies Inc. (NASDAQ: POET) is trading around $4.68 per share, up roughly 1–2% on the day from a previous close near $4.61. That price values the photonics and AI-connectivity specialist at about $600 million in market capitalization, depending on the data provider. Stock Titan+1 The stock has been on a violent ride. Over the past 52 weeks, POET shares have swung between $3.09 and $9.41, highlighting the name’s high volatility and speculative profile. Public+1 Price history over the
3 December 2025
····
CrowdStrike (CRWD) Stock on December 3, 2025: Earnings Beat, AI Guidance and New Price Targets

CrowdStrike (CRWD) Stock on December 3, 2025: Earnings Beat, AI Guidance and New Price Targets

CrowdStrike Holdings, Inc. (NASDAQ: CRWD) just turned December 2–3, 2025 into a major checkpoint for anyone watching high‑growth cybersecurity and AI stocks. The company delivered another “beat and raise” quarter, guided above Wall Street expectations, and rolled out more AI‑driven ambitions for its Falcon platform. At the same time, the stock is wobbling slightly after a huge run, and the valuation debate is getting louder. Here’s a full breakdown of where CrowdStrike stock stands as of December 3, 2025, including the latest news, forecasts and analysis. CrowdStrike stock today: price, performance and volatility As of the last full trading day
3 December 2025
·
Marvell Technology (MRVL) Soars on Celestial AI Deal and Record Q3 Earnings: What Investors Need to Know Now

Marvell Technology (MRVL) Soars on Celestial AI Deal and Record Q3 Earnings: What Investors Need to Know Now

Updated December 3, 2025 Marvell Technology, Inc. (NASDAQ: MRVL) has jumped back into the AI spotlight after reporting record fiscal Q3 2026 results and announcing a multibillion‑dollar acquisition of optical‑interconnect startup Celestial AI. Together, the earnings beat and the deal are reshaping Wall Street’s view of the mid‑cap chipmaker as a core enabler of AI data centers rather than just another networking name. TipRanks+3Marvell Technology, Inc.+3Marvell Technology, Inc.+3 As of mid‑day trading on December 3, 2025, Marvell shares were changing hands around $92.89, up roughly 2% on the day, giving the company a market capitalization of about $80 billion and
3 December 2025
·····
Haleon PLC (HLN) Stock on 3 December 2025: Earnings Miss, ESG Wins and Analyst Upgrades Shape the Outlook

Haleon PLC (HLN) Stock on 3 December 2025: Earnings Miss, ESG Wins and Analyst Upgrades Shape the Outlook

Quick snapshot (as of 3 December 2025) Let’s unpack what’s going on with Haleon stock right now and what the latest news and forecasts suggest. Where Haleon stock sits today In London, Haleon shares trade around 368–370p, with recent data showing: On the NYSE, Haleon’s ADRs change hands at about $9.7, not far from the middle of their 52‑week range (roughly $8.7–$11.4 according to multiple data providers). Directors Talk Interviews+1 So you’ve got a global consumer health giant valued similarly on both sides of the Atlantic: mid‑20s earnings multiple, sub‑2% dividend yield, and a business profile that’s meant to be
3 December 2025
·
Paragon Banking Group (PAG.L) Shares Drop After FY 2025 Results: Dividend Hike, £50m Buyback and 2026 Margin Squeeze Explained

Paragon Banking Group (PAG.L) Shares Drop After FY 2025 Results: Dividend Hike, £50m Buyback and 2026 Margin Squeeze Explained

Paragon Banking Group PLC shares fell sharply on 3 December 2025 despite the specialist lender reporting another year of robust profits, rising dividends and a fresh share buyback programme. The market reaction focused less on the 2025 numbers and more on guidance for a squeeze in net interest margins in 2026 and higher provisions linked to UK motor finance redress. Below is a detailed look at what the latest results mean for the Paragon Banking Group share price, dividend outlook and analyst forecasts. Paragon Banking Group share price on 3 December 2025 At the London market close on 3 December
3 December 2025
···
Compass Group PLC Stock on 3 December 2025: Near 52‑Week Lows Despite Double‑Digit Earnings Growth

Compass Group PLC Stock on 3 December 2025: Near 52‑Week Lows Despite Double‑Digit Earnings Growth

Published: 3 December 2025 – For information only, not investment advice. Share price today: quality business, tired share price Compass Group PLC (LON: CPG) is ending 2025 in an awkward position: the business is putting up strong numbers, but the share price is behaving like it has lost its appetite. As of the close on 3 December 2025, Compass shares trade around 2,338p in London, with a bid–ask spread of 2,337p–2,339p. Hargreaves Lansdown+1 Key market stats today: In other words, investors are getting a blue‑chip compounder at a price the market last saw during brief drawdowns, not during boom times.
3 December 2025
·
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

As of early December 3, 2025, Elevance Health, Inc. (NYSE: ELV) is trading around $331 per share, leaving the managed-care giant roughly 30% below its 52‑week high near $459, even after a strong third‑quarter earnings beat and renewed institutional buying.Investing.com+1 Over the past 12 months the stock is down about 18%, significantly lagging the S&P 500.PortfoliosLab This article pulls together the latest news, forecasts and analysis available as of December 2, 2025, to give a comprehensive view of where Elevance Health stock stands now and what markets are pricing in for 2026 and beyond. 1. Where Elevance Health Stock Stands
3 December 2025
·
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Company (NYSE: MMM) has quietly turned into one of 2025’s comeback stories on Wall Street. After years of legal headaches and sluggish growth, the industrial conglomerate now sits near a four‑year high, closing at $171.56 on 2 December 2025, just shy of its 52‑week peak around $172.85. That price gives 3M a market capitalization of about $91 billion, a trailing P/E of 27.4 and a forward P/E near 20.3, with a dividend yield around 1.7% on an annual payout of $2.92 per share. StockAnalysis Yet beneath the smooth headline numbers, investor views on 3M are sharply divided. Some see
3 December 2025
···
1 … 161 162 163 164 165 … 202

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Go toTop